Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant720 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02519140 | Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections | withdrawn | Phase 3 | 0 | Antonios LikourezosOTHER | 1 | Dec 4, 2023 | clinicaltrials |
| NCT04859582 | Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)-China Extension | withdrawn | Phase 3 | 0 | Merck Sharp & Dohme LLCINDUSTRY | 1 | Dec 16, 2021 |
| NCT01470742 | Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric Cancer | withdrawn | Phase 3 | 0 | Samsung Medical CenterOTHER | 1 | Dec 30, 2019 | clinicaltrials |
| NCT02736552 | Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB. | withdrawn | Phase 3 | 0 | Fudan UniversityOTHER | 1 | May 8, 2019 | clinicaltrials |
| NCT00622804 | Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy | withdrawn | Phase 3 | 90 | The Catholic University of KoreaOTHER | 1 | Aug 3, 2009 | clinicaltrials |
Data updated 22 days agoSource updated Dec 4, 2023source: clinicaltrials